Primary Dysautonomias: Clinical Trials

14 trials for Primary Dysautonomias, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 14

Follow Primary Dysautonomias: new trials by email Literature Review of Primary Dysautonomias trials Research Report on Primary Dysautonomias

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial of Parkinson's And Zoledronic Acid
Zoledronic Acid 5Mg/Bag 100Ml Inj, Placebo - Parkinson Disease, Osteoporosis
Phase 4CompletedCalifornia Pacific Medical Center Research Institute27212019-11-152026-06-25
Lundbeck TOMs Orthostatic Hypotension
Droxidopa 100 MG [Northera] - Orthostatic Hypotension, Idiopathic Parkinson Disease
Phase 4CompletedAlberto Espay, MD, MSc92019-02-112022-09-26
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
Northera, Placebo - Hypotension, Orthostatic, Hypotension
Phase 4CompletedJames J. Peters Veterans Affairs Medical Center222018-06-012025-03-07
Efficacy and Safety of Midodrine and Atomoxetine for Neurogenic OH
Midodrine, Atomoxetine - Neurogenic Orthostatic Hypotension
Phase 4CompletedSeoul National University Hospital502018-01-012019-04-05
Dawn Simulation and Postural Hypotension
Light - Orthostatic Hypotension
Phase 4CompletedVA Palo Alto Health Care System352016-09-012019-10-25
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
Droxidopa capsules, Placebo capsules - Symptomatic Neurogenic Orthostatic Hypotension
Phase 4CompletedH. Lundbeck A/S4532016-02-112023-08-23
Effect of Medical Treatment and Prognosis of Postural Orthostatic Tachycardia Syndrome (POTS)
Propranolol, Bisoprolol, Propranolol+pyridostigmine - Postural Orthostatic Tachycardia Syndrome
Phase 4CompletedSeoul National University Hospital1502014-03-012018-04-18
Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic Hypotension
Midodrine HCl, Placebo - Orthostatic Hypotension
Phase 4CompletedShire242012-05-142021-06-08
Optimal Balloon Catheter Placement During Sonohysterography
sonohysterography with inflated catheter in uterine cavity, sonohysterography with inflated catheter in cervical cavity - Infertility
Phase 4CompletedRoyan Institute3002012-05-012014-05-06
Heart Rate Variability in Fibromyalgia - Effects of Strengthening Exercises
strengthening exercise, flexibility exercise - Fibromyalgia
Phase 4CompletedFederal University of Espirito Santo662010-07-012013-12-09
Clinical Trial for the Prevention of Vasovagal Syncope
fludrocortisone acetate - Syncope, Vasovagal, Neurally-Mediated
Phase 4CompletedUniversity of Calgary2132005-05-012019-10-15
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
Midodrine hydrochloride, Placebo - Hypotension, Orthostatic
Phase 4CompletedShire242004-09-082021-06-14
Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance
Propranolol - Neurocardiogenic Syncope
Phase 4CompletedNational Institute of Neurological Disorders and Stroke (NINDS)242003-05-012008-03-04
A Study for Patients With Neurogenic Orthostatic Hypotension
Midodrine Hydrochloride - Hypotension, Orthostatic
Phase 4CompletedShire1401997-12-012021-06-11

Narrower conditions

Hypotension, Orthostatic (7)  ·  Parkinson Disease (3)  ·  Syncope, Vasovagal (3)  ·  Multiple System Atrophy (2)  ·  Autonomic Nervous System Diseases (1)  ·  Fibromyalgia (1)  ·  Fractures, Bone (1)  ·  Hypotension (1)  ·  Infertility (1)  ·  Lewy Body Disease (1)  ·  Motor Activity (1)  ·  Orthostatic Intolerance (1)  ·  Osteoporosis (1)  ·  Parkinsonian Disorders (1)  ·  Postural Orthostatic Tachycardia Syndrome (1)

Broader conditions

Nervous System Diseases (14)  ·  Autonomic Nervous System Diseases (13)  ·  Orthostatic Intolerance (10)  ·  Cardiovascular Diseases (7)  ·  Vascular Diseases (7)  ·  Hypotension (6)  ·  Central Nervous System Diseases (4)  ·  Neurologic Manifestations (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Signs and Symptoms (4)  ·  Basal Ganglia Diseases (3)  ·  Brain Diseases (3)  ·  Consciousness Disorders (3)  ·  Movement Disorders (3)

Interventions

Midodrine (4)  ·  Droxidopa (3)  ·  Propranolol (2)  ·  Atomoxetine Hydrochloride (1)  ·  Bisoprolol (1)  ·  Ultraviolet Therapy (1)  ·  Zoledronic Acid (1)  ·  fludrocortisone acetate (1)

Sponsors

Shire (3)  ·  Seoul National University Hospital (2)  ·  Alberto Espay, MD, MSc (1)  ·  California Pacific Medical Center Research Institute (1)  ·  Federal University of Espirito Santo (1)  ·  H. Lundbeck A/S (1)  ·  James J. Peters Veterans Affairs Medical Center (1)  ·  National Institute of Neurological Disorders and Stroke (NINDS) (1)  ·  Royan Institute (1)  ·  University of Calgary (1)  ·  VA Palo Alto Health Care System (1)

Countries

United States (10)  ·  South Korea (2)  ·  Brazil (1)  ·  Canada (1)  ·  Iran (1)

Top investigators

Chu Kon (1)  ·  Fatemeh Zafarani, MSc (1)  ·  Firoozeh Ahmadi, MD (1)  ·  Hamid Gourabi, PhD (1)  ·  Jill M Wecht, Ed.D (1)  ·  Kon Chu, MD, PhD (1)  ·  Maria Bernadete RO Gavi, Master (1)  ·  Robert S. Sheldon, MD PhD (1)  ·  Steve Cummings, MD (1)

Results publications

PMID 16781217, PMID 24651512, PMID 27364043, PMID 27372462, PMID 29500811, PMID 29766871, PMID 32307533, PMID 33649343, PMID 35107750

NIH funding

R01AG059417 (1)